Leronlimab - Disease List (currently 90)

(updated 12-09-2021)

An incomplete list of potential treatment targets for leronlimab.

AA Amyloidosis
Acute Respiratory Distress Syndrome
Allergies (anaphylactic shock)
Alopecia Areata
Alzheimer's
Amyotrophic Lateral Sclerosis
Angioedema
Anthrax
Aplastic Anemia
Asthma
Atherosclerosis
Atopic Dermatitis
Cancer
Castleman Disease
Celiac Disease
Coeliac Disease
Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
Chronic Inflammatory Demyelinating Polyneuropathy
Chronic Kidney Disease (due to inflammation)
Chronic Traumatic Encephalopathy
COPD
COVID-19 (and other coronaviruses)
COVID-19 longhaulers syndrome (PASC)
Crohn's Disease
Colitis
Cystic Fibrosis (anti-inflammatory in combo with CFTR modulators)
Dermatomyositis
Diabetes (type 1 and 2)
Duchenne Muscular Dystrophy
Emphysema
Endometriosis
Eosinophilic Esophagitis
Epilepsy (reduction in frequency and severity)
Fibromyalgia
FMF Related Amyloidosis
Fragile X Syndrome
Gout
Grave’s Disease
Guillain-Barre Syndrome
GVHD
Hashimoto’s Thyroiditis
Henoch–Schönlein Purpura
Hepatitis (autoimmune)
HIV
Huntington's Disease
Idiopathic Pulmonary Fibrosis
Immune Thrombocytopenia
Inclusion Body Myositis
Inflammatory Bowel Disease
Influenza (severe)
Kawasaki Syndrome
Lambert-Eaton Syndrome
Lewy Body Dementia
Lupus
Lyme Disease
Lymphedema
Marshall’s syndrome (PFAPA)
Mesenteric Panniculitis
Miller Fisher Syndrome
Multiple Sclerosis
Myasthenia Gravis
Myocarditis
NASH
Necrotizing Autoimmune Myopathy
Neurofibromatosis
Osteoarthritis
Osteomyelitis
Parkinson's Disease
Pemphigus
Peyronie's Disease (treatment of underlying autoimmune condition)
Pneumonia
Polymyositis
Post-Myocardial Infarction Syndrome
Psoriasis
Pulmonary Arterial Hypertension
Pulmonary Fibrosis
Rett Syndrome
Rheumatic Fever
Rheumatoid Arthritis
Sarcoidosis
Scleroderma
Sepsis
Sickle Cell Disease (anti-inflammatory and anti-hypercoagulability effect)
Sjogren’s Syndrome
Still’s Disease
Stroke
Trigeminal Neuralgia
Tuberculosis
Vasculitis
Wegener’s Granulomatosis